You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
Canopy Growth Reports Third Quarter Fiscal Year 2024 Financial Results; Achieves Third Quarter of Sequential Revenue Growth across Canada Cannabis Businesses and a Record Quarter for Medical Sales Canada...
Aurora Cannabis Acquires MedReleaf Australia Aurora becomes the largest global medical cannabis company operating in nationally legal markets. MedReleaf Australia holds the #2 position in medical cannabis within the...
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
As we described in a previous article, the Global Cannabis Stock Index extended the bounce from November after the huge October loss, rallying 8.1% in December. That index was down 20.1% in 2023,...
Cannabis stocks, as measured by the Global Cannabis Stock Index, exploded higher in late August on news that the Department of Health and Human Services had recommended to the DEA...
High Tide Releases Audited 2023 Financial Results Featuring Record Fourth Quarter Revenue of $127.1 Million, Record Adjusted EBITDA of $8.4 Million and Record Free Cash Flow of $5.7 Million,...
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
Organigram Announces the First Tranche Closing from BAT Investment TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today...
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
Statistics Canada released November retail sales for the country, with cannabis sales decreasing from the strong October levels, down 6.2% to C$412.1 million. October was revised lower to C$439.3 million. The sales,...
Canopy Growth Announces Upsized US$35 Million Private Placement SMITHS FALLS, ON, Jan. 18, 2024 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), today...
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
Canopy Growth Announces US$30 Million Private Placement SMITHS FALLS, ON, Jan. 9, 2024 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), today announced...
Record Q2 Net Revenue of $194 Million, Increases 34% Over the Prior Year Period Global Cannabis Leader with #1 Market Share in Canada and 31% Growth in Canadian...
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
As we described in a previous article, the Global Cannabis Stock Index extended the November bounce after the huge October loss, rallying 8.1% in December. That index was down 20.1% in 2023, which...
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
Cannabis stocks, as measured by the Global Cannabis Stock Index, exploded higher in late August on news that the Department of Health and Human Services had recommended to the DEA...
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
Statistics Canada released October retail sales for the country, with cannabis sales increasing from the very weak September levels, up 2.4% to C$448.6 million. September was revised lower to C$438.0 million. The...
Organigram Reports Fiscal 2023 Results¹ Domestic share growth in several key categories continues to be driven by innovation excellence and industry-leading R&D. Organigram continues to take a leadership position...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
As we described in a previous article, the Global Cannabis Stock Index rebounded 8.1% in November after a huge October loss. That index is now down 20.1% year-to-date, which has followed a...
